Teleflex Inc (TFX) reports a 2.8% revenue increase and a 15.1% rise in adjusted EPS, while announcing a strategic acquisition and share repurchase program to drive future growth.

After the split, Teleflex would focus on devices for bloodstream and heart procedures, along with medical imaging, while ...

Good morning, ladies and gentlemen, and welcome to the Teleflex Fourth Quarter 2024 Earnings Conference Call. At this time all participants have been placed in a listen-only mode. At the end of the ...

Piper Sandler analyst Matt O’Brien downgraded Teleflex (TFX) to Neutral from Overweight with a price target of $140, down from $255. The ...

Teleflex's business units, including urology and acute care will come under NewCo, with interventional and surgical under ...

Teleflex Incorporated TFX posted fourth-quarter 2024 adjusted earnings per share (EPS) from continuing operations of $3.89, ...

The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research ...

Teleflex to create a new, independent publicly traded company consisting of its Urology, Acute Care, and OEM businesses.

Citizens JMP downgraded Teleflex (TFX) to Market Perform from Outperform without a price target The company this morning reported Q4 results ...